Structure Therapeutics GPCR
NASDAQ GPCR
$32.69 -2.38 (-6.77%)
At close: Sep 29, 2026 · 4:00 PM EDT

Structure Therapeutics (GPCR) Interest & Investment Income (2022 - 2026)

Updated

Structure Therapeutics (GPCR) posted Interest & Investment Income of $12.71 million for Q2 2026, up 42.3% from $8.93 million a year earlier but down 6.6% from the prior quarter.

Analysis

Structure Therapeutics (GPCR) Interest & Investment Income (2022 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Interest & Investment Income at Structure Therapeutics was $43.67 million, up 6.1% year-over-year; for FY2025, it was $35.87 million, down 0.4% from FY2024.

  • Annual Interest & Investment Income shows a three-year compound annual growth rate of 205.6% (FY2022 to FY2025).
  • In prior years, Structure Therapeutics' Interest & Investment Income was $36.01 million in FY2024 (+168.9%), $13.39 million in FY2023 (+965.3%) and $1.26 million in FY2022.
  • Quarterly Interest & Investment Income has run from a low of -$69,000 in Q1 2022 to a high of $13.6 million in Q1 2026 over five years.
  • On a year-over-year basis, Interest & Investment Income increased in six of the last eight quarters, with growth averaging 67.2%.
  • The strongest year-over-year quarter for Interest & Investment Income in the past five years was Q3 2023, with growth of 670.2%; the weakest was Q3 2025, with a decline of 31.5%.
  • According to Business Quant data, Interest & Investment Income for the three prior quarters was $13.6 million (Q1 2026), $9.19 million (Q4 2025) and $8.18 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 219.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 80.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 120.60 Mn
10 Structure Therapeutics 7.49 Bn 7.49 Bn - 12.71 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.71 Mn
Mar 31, 2026 13.60 Mn
Dec 31, 2025 9.19 Mn
Sep 30, 2025 8.18 Mn
Jun 30, 2025 8.93 Mn
Mar 31, 2025 9.58 Mn
Dec 31, 2024 10.72 Mn
Sep 30, 2024 11.95 Mn
Jun 30, 2024 7.34 Mn
Mar 31, 2024 6.01 Mn
Dec 31, 2023 6.18 Mn
Sep 30, 2023 2.69 Mn
Jun 30, 2023 2.83 Mn
Mar 31, 2023 1.70 Mn
Dec 31, 2022 901,000.00
Sep 30, 2022 349,000.00
Jun 30, 2022 76,000.00
Mar 31, 2022 -69,000.00
API Access

Structure Therapeutics Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=GPCR&period=max&api_key=YOUR_API_KEY